持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/07/27 | 8,280 | 8,430 | 8,240 | 8,400 | +110 | +1.3% | 20,300 |
| 2018/07/26 | 8,150 | 8,290 | 8,080 | 8,290 | +230 | +2.9% | 20,300 |
| 2018/07/25 | 8,070 | 8,080 | 8,010 | 8,060 | -10 | -0.1% | 6,400 |
| 2018/07/24 | 8,180 | 8,180 | 8,040 | 8,070 | -20 | -0.2% | 9,800 |
| 2018/07/23 | 8,020 | 8,160 | 8,020 | 8,090 | +30 | +0.4% | 8,000 |
| 2018/07/20 | 8,060 | 8,170 | 8,040 | 8,060 | -60 | -0.7% | 12,900 |
| 2018/07/19 | 8,190 | 8,190 | 8,060 | 8,120 | -10 | -0.1% | 9,100 |
| 2018/07/18 | 8,190 | 8,190 | 8,070 | 8,130 | +50 | +0.6% | 8,600 |
| 2018/07/17 | 7,980 | 8,120 | 7,960 | 8,080 | +180 | +2.3% | 23,000 |
| 2018/07/13 | 7,800 | 7,940 | 7,800 | 7,900 | +120 | +1.5% | 10,200 |
| 2018/07/12 | 7,840 | 7,880 | 7,780 | 7,780 | ±0 | ±0% | 10,500 |
| 2018/07/11 | 7,850 | 7,850 | 7,730 | 7,780 | -100 | -1.3% | 13,100 |
| 2018/07/10 | 7,920 | 8,100 | 7,880 | 7,880 | -40 | -0.5% | 18,000 |
| 2018/07/09 | 7,840 | 7,980 | 7,790 | 7,920 | +80 | +1% | 16,600 |
| 2018/07/06 | 7,880 | 7,910 | 7,810 | 7,840 | +40 | +0.5% | 14,200 |
| 2018/07/05 | 7,890 | 7,930 | 7,760 | 7,800 | -120 | -1.5% | 9,600 |
| 2018/07/04 | 7,700 | 7,950 | 7,690 | 7,920 | +130 | +1.7% | 12,300 |
| 2018/07/03 | 7,810 | 7,850 | 7,720 | 7,790 | -50 | -0.6% | 20,000 |
| 2018/07/02 | 8,070 | 8,090 | 7,810 | 7,840 | -230 | -2.9% | 16,400 |
| 2018/06/29 | 8,100 | 8,140 | 7,860 | 8,070 | ±0 | ±0% | 19,400 |
| 2018/06/28 | 8,160 | 8,160 | 8,040 | 8,070 | -120 | -1.5% | 28,500 |
| 2018/06/27 | 8,200 | 8,250 | 8,160 | 8,190 | ±0 | ±0% | 13,600 |
| 2018/06/26 | 8,090 | 8,190 | 8,050 | 8,190 | +140 | +1.7% | 11,800 |
| 2018/06/25 | 8,190 | 8,190 | 8,020 | 8,050 | -150 | -1.8% | 11,000 |
| 2018/06/22 | 8,230 | 8,230 | 8,180 | 8,200 | +10 | +0.1% | 18,700 |
| 2018/06/21 | 8,050 | 8,260 | 8,050 | 8,190 | +40 | +0.5% | 17,200 |
| 2018/06/20 | 8,020 | 8,180 | 8,020 | 8,150 | +40 | +0.5% | 16,600 |
| 2018/06/19 | 8,190 | 8,190 | 8,090 | 8,110 | -20 | -0.2% | 10,400 |
| 2018/06/18 | 8,200 | 8,200 | 8,090 | 8,130 | -30 | -0.4% | 10,000 |
| 2018/06/15 | 8,190 | 8,260 | 8,130 | 8,160 | -110 | -1.3% | 25,800 |
| 2018/06/14 | 8,300 | 8,330 | 8,220 | 8,270 | -100 | -1.2% | 18,200 |
| 2018/06/13 | 8,200 | 8,430 | 8,170 | 8,370 | +210 | +2.6% | 26,900 |
| 2018/06/12 | 8,050 | 8,190 | 8,020 | 8,160 | +150 | +1.9% | 22,700 |
| 2018/06/11 | 7,980 | 8,040 | 7,940 | 8,010 | +110 | +1.4% | 7,300 |
| 2018/06/08 | 7,850 | 7,930 | 7,830 | 7,900 | -10 | -0.1% | 23,300 |
| 2018/06/07 | 7,870 | 7,950 | 7,790 | 7,910 | +100 | +1.3% | 13,800 |
| 2018/06/06 | 7,850 | 7,870 | 7,760 | 7,810 | -100 | -1.3% | 19,500 |
| 2018/06/05 | 7,970 | 7,970 | 7,850 | 7,910 | -10 | -0.1% | 12,300 |
| 2018/06/04 | 7,890 | 7,990 | 7,850 | 7,920 | +160 | +2.1% | 25,100 |
| 2018/06/01 | 7,700 | 7,840 | 7,690 | 7,760 | +20 | +0.3% | 15,400 |
| 2018/05/31 | 7,730 | 7,750 | 7,700 | 7,740 | -20 | -0.3% | 29,800 |
| 2018/05/30 | 7,780 | 7,850 | 7,750 | 7,760 | -170 | -2.1% | 16,200 |
| 2018/05/29 | 7,920 | 7,970 | 7,860 | 7,930 | -50 | -0.6% | 13,900 |
| 2018/05/28 | 8,090 | 8,100 | 7,950 | 7,980 | -110 | -1.4% | 12,400 |
| 2018/05/25 | 8,060 | 8,140 | 8,060 | 8,090 | -40 | -0.5% | 12,300 |
| 2018/05/24 | 8,260 | 8,270 | 8,130 | 8,130 | -70 | -0.9% | 14,100 |
| 2018/05/23 | 8,170 | 8,230 | 8,120 | 8,200 | +10 | +0.1% | 17,400 |
| 2018/05/22 | 8,090 | 8,230 | 8,090 | 8,190 | +70 | +0.9% | 20,300 |
| 2018/05/21 | 8,160 | 8,230 | 8,090 | 8,120 | -110 | -1.3% | 18,500 |
| 2018/05/18 | 8,270 | 8,280 | 8,170 | 8,230 | -10 | -0.1% | 21,200 |
1701～
1750
件表示中 / 3743件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 294,500円 | +5.1% | -7.0% | 2.72% | 19.33倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| サンバイオ | 208,100円 | - | - | 0.00% | - | 96.39倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ゼリア新薬 | 207,100円 | +3.1% | -6.5% | 2.32% | 9.61倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,800円 | -2.4% | -52.3% | 3.81% | 17.93倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 68,600円 | +14.3% | - | 2.92% | 27.86倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
